*Department of Neurology, Duke University Medical Center, Durham, North Carolina, U.S.A.; and
†Neurodiagnostic Center, Veterans Affairs Medical Center, Durham, North Carolina, U.S.A.
Address correspondence and reprint requests to Saurabh R. Sinha, MD, PhD, 295 Hanes House, 330 Trent Drive, Box 102350 Duke University Medical Center, Durham, NC 27710, U.S.A.; e-mail: [email protected].
S. R. Sinha has received research support from UCB Pharma, Cyberonics, Upsher-Smith Laboratories, and Schwarz Pharma. He has received honoraria for lectures from UCB Pharma, Lundbeck and Cyberonics. He has provided consultation to Pfizer, Accorda, Upsher-Smith Laboratories, and Lundbeck. K. E. Dombrowski has received research support from Jordan Neuroscience, Optima Neuroscience, Sage Therapeutics, UCB Pharma, and Sanofi Aventis. A. M. Husain has received research support from UCB Pharma, Pfizer, Upsher-Smith Laboratories. He has received honoraria for lectures from UCB Pharma, Jazz Pharma. He has provided consultation to UCB Pharma, Upsher-Smith Laboratories, Jazz Pharma. He has received royalties from Demos Publishers for two books he has edited. B. J. Kolls has received research funding from Jordan Neuroscience, UCB Pharma, Optima Neuroscience, Medtronics and BrainScope Company, Inc. R. R. Radtke has received honoraria for lectures from UCB Pharma. He has provided consultation to UCB Pharma, Sunovian, Lundbeck, Easai, Supernus, Upsher-Smith, and Acorda. T. Tran has received honoraria for lectures from UCB Pharma.
Presented in part at the American Epilepsy Society Annual Meeting. Washington D.C., December 2013 and at Neurocritical Care Society Meeting, Philadelphia, PA, October 2013.
